We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $84.33 · 15 analysts
Stored first · Google News · Yahoo Finance (English)
Enterprise value to EBIT forward of Eastman Chemical Company – BX:EAC - TradingView
Enterprise value to EBIT forward of Eastman Chemical Company – BX:EAC TradingView
A Look at Eastman Chemical Co (EMN) After 3.9% Decline -- GF Val - GuruFocus
A Look at Eastman Chemical Co (EMN) After 3.9% Decline -- GF Val GuruFocus
Eastman Chemical Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Eastman Chemical Co. stock underperforms Wednesday when compared to competitors MarketWatch
Eastman Schedules Second-Quarter 2026 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast, and Release of Additional Information
Can DOW's Strong Liquidity Drive Future Growth and Returns?
Eastman Chemical Co. stock outperforms competitors on strong trading day - MarketWatch
Eastman Chemical Co. stock outperforms competitors on strong trading day MarketWatch
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 30. | After market close (AMC) | $1.81 | — | — | $2.41B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $1.57 | — | — | $2.29B | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $4.86 | — | — | $7.14B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $3.33 | — | — | $4.67B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 06. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 05. 05. | RBC Capital | — | Maintain | Sector Perform → Sector Perform | — | RBC Capital: Sector Perform |
| 2026. 05. 05. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 05. 05. | Wells Fargo | — | Maintain | Equal-Weight → Equal-Weight | — | Wells Fargo: Equal-Weight |
| 2026. 05. 05. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 04. 17. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.